Mayne Pharma | 贸易债权人

股票价格
2.63
每天变化
-0.07 -2.59%
每月一次
-17.81%
每年
-43.80%
Q1 预测
2.58


金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.89
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 223.75M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 195.04M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


贸易债权人 更改 日
Ansell USD 250.9M 25.4M 2025-06
Avita Medical AUD 7.27M 976K 2025-06
Cochlear AUD 298.4M 12.9M 2025-06
CSL USD 3.46B 484M 2025-06
Healius AUD 133.9M 45.9M 2025-06
Integral Diagnostics AUD 28.28M 17.87M 2023-12
Medical Developments International AUD 6.49M 1.35M 2025-06
Nanosonics AUD 1.53M 8.56M 2025-06
Polynovo AUD 6.39M 2.84M 2024-06
Ramsay Health Care AUD 1.73B 76.3M 2025-06
ResMed USD 250.41M 16.36M 2025-12
Sigma Healthcare AUD 1.32B 970.03M 2025-12
Sonic Healthcare AUD 313.54M 543.93M 2024-06
Telix Pharmaceuticals AUD 68.7M 46.4M 2024-12


Mayne Pharma 贸易债权人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.